These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7577094

  • 1. Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
    Douay L, Hu C, Giarratana MC, Gorin NC.
    Eur J Cancer; 1995; 31A Suppl 1():S14-6. PubMed ID: 7577094
    [Abstract] [Full Text] [Related]

  • 2. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L, Hu C, Giarratana MC, Bouchet S, Conlon J, Capizzi RL, Gorin NC.
    Blood; 1995 Oct 01; 86(7):2849-55. PubMed ID: 7670119
    [Abstract] [Full Text] [Related]

  • 3. The potential role of amifostine (Ethyol) in haematological malignancies.
    Gorin NC.
    Eur J Cancer; 1996 Oct 01; 32A Suppl 4():S31-9. PubMed ID: 8976820
    [Abstract] [Full Text] [Related]

  • 4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar 01; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants.
    Douay L, Hu C, Giarratana MC, Gorin NC.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 11):16-20. PubMed ID: 7973773
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M, Grisanti S, Granzow K, Saladini A, Sala A, Nozza A, Molteni A, Passamonti F, Carlo-Stella C, Santoro A, Siena S.
    Semin Oncol; 1999 Apr 01; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [Abstract] [Full Text] [Related]

  • 7. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
    Douay L, Giarratana MC, Labopin M, Bardinet D, Bouchet S, Gorin NC.
    Bone Marrow Transplant; 1995 May 01; 15(5):769-75. PubMed ID: 7670404
    [Abstract] [Full Text] [Related]

  • 8. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
    Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC, McCulloch W.
    Blood; 1994 Jun 01; 83(11):3132-7. PubMed ID: 8193351
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R, Grünebach F, Bader P, Vogel W, Kanz L, Brugger W, Scheding S.
    J Hematother Stem Cell Res; 2001 Dec 01; 10(6):777-85. PubMed ID: 11798504
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
    Domenech J, Desbois I, Linassier C, Gihana E, Chenault S, Brémond JL, Colombat P, Lamagnère JP, Binet C.
    Bone Marrow Transplant; 1993 Jun 01; 11(6):425-31. PubMed ID: 8334422
    [Abstract] [Full Text] [Related]

  • 11. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec 01; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 12. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC, Gorin NC, Douay L.
    Nouv Rev Fr Hematol (1978); 1995 Dec 01; 37(2):125-30. PubMed ID: 7644349
    [Abstract] [Full Text] [Related]

  • 13. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
    Fauth F, Martin H, Sonnhoff S, Bialleck H, Wiesneth M, Mihanovic B, Hoelzer D.
    Bone Marrow Transplant; 2000 Apr 01; 25(8):831-6. PubMed ID: 10808203
    [Abstract] [Full Text] [Related]

  • 14. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec 01; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R, Bony V, Lopez M.
    Prog Clin Biol Res; 1994 Dec 01; 389():23-9. PubMed ID: 7700906
    [No Abstract] [Full Text] [Related]

  • 16. Use of amifostine in bone marrow purging.
    Cagnoni PJ, Jones RB, Bearman SI, Ross M, Hami L, Franklin WA, Capizzi R, Schein PS, Shpall EJ.
    Semin Oncol; 1996 Aug 01; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [Abstract] [Full Text] [Related]

  • 17. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 18. Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery.
    Poloni A, Leoni P, Curzi L, Cantori I, Mancini S, Montanari M, Masia MC, Olivieri A.
    Exp Hematol; 1999 Oct 01; 27(10):1548-56. PubMed ID: 10517497
    [Abstract] [Full Text] [Related]

  • 19. Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.
    Rizzoli V, Mangoni L, Piovani G, Garau D, Caramatti C, Almici C, Carlo-Stella C.
    Leuk Lymphoma; 1993 Oct 01; 11 Suppl 1():109-12. PubMed ID: 8251884
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM.
    Blood; 1989 Jul 01; 74(1):501-6. PubMed ID: 2665843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.